SCHEMBL8569498

SCHEMBL8569498

CCc1ccc2c(c1)[C@@H](CCN)CCC2

nearest known ligand 0.47

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 3/20 0.39
SIGMAR1 Q99720 2/20 0.39
MTNR1B P49286 2/20 0.39
NQO2 P16083 1/20 0.39
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
KDM4C Q9H3R0 2/20 0.38
DRD2 P14416 1/20 0.38
DRD1 P21728 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8521850 1.00 MTNR1A (0.39) MTNR1ASIGMAR1MTNR1BNQO2ESR1
Hydrochloric Acid SCHEMBL8604303 0.98 MTNR1A (0.39) MTNR1ASIGMAR1MTNR1BNQO2ESR1
Hydrochloric Acid SCHEMBL8604302 0.98 MTNR1A (0.39) MTNR1ASIGMAR1MTNR1BNQO2ESR1
SCHEMBL8033089 0.93 SIGMAR1 (0.42) MTNR1ASIGMAR1DRD2
SCHEMBL8568951 0.88 MTNR1A (0.38) MTNR1ASIGMAR1MTNR1BNQO2ESR1
SCHEMBL8568956 0.88 MTNR1A (0.38) MTNR1ASIGMAR1MTNR1BNQO2ESR1
SCHEMBL8521537 0.86 CTSD (0.41) SIGMAR1DRD2
SCHEMBL8575802 0.86 CTSD (0.41) SIGMAR1DRD2
SCHEMBL8034996 0.83 MTNR1A (0.37) MTNR1ASIGMAR1MTNR1BNQO2ESR1
SCHEMBL8031506 0.82 SIGMAR1 (0.41) SIGMAR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0721938-B1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 1999-12-08 EP disclosed
US-5780512-A MELATONINERGIC ADIR ET COMPAGNIE (FR) 1998-07-14 US disclosed
US-5693665-A TREATING MELATONINERGIC DISORDERS ADIR ET COMPAGNIE (FR) 1997-12-02 US disclosed
EP-0721938-A1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1996-07-17 EP disclosed